From: Measuring research impact: a large cancer research funding programme in Australia
Research category | Paper | Citations (Google scholar 2013) |
---|---|---|
Clinical | Falchook G, Long G, Kurzrock R, Kim K, Arkenau T, Brown M, et al. Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. Lancet. 2012;379(9829):1893–901. | 136 |
Biomedical | Chau N, Mackenzie P, Miners J. The contribution of human udp-glucuronosyltransferase enzymes to the glucosidation of mycophenolic acid. Drug Metab Rev. 2014;45:S1. | 129 |
Population/health services | Hutchinson A, Wilson C. Improving nutrition and physical activity in the workplace: a meta-analysis of intervention studies. Health Promot Int. 2012;27:2. | 14 |